Cross-presentation of synthetic long peptides by human dendritic cells: a process dependent on ERAD component p97/VCP but Not sec61 and/or Derlin-1.
about
Cross-Presentation of Cell-Associated Antigens by MHC Class I in Dendritic Cell SubsetsComparison of Intranasal Outer Membrane Vesicles with Cholera Toxin and Injected MF59C.1 as Adjuvants for Malaria Transmission Blocking Antigens AnAPN1 and Pfs48/45.Improved Transgenic Mouse Model for Studying HLA Class I Antigen Presentation.Surrogate in vitro activation of innate immunity synergizes with interleukin-7 to unleash rapid antigen-driven outgrowth of CD4+ and CD8+ human peripheral blood T-cells naturally recognizing MUC1, HER2/neu and other tumor-associated antigens.The ongoing saga of the mechanism(s) of MHC class I-restricted cross-presentation.Long-Peptide Cross-Presentation by Human Dendritic Cells Occurs in Vacuoles by Peptide Exchange on Nascent MHC Class I Molecules.Intracellular recycling and cross-presentation by MHC class I molecules.Spatial separation of the processing and MHC class I loading compartments for cross-presentation of the tumor-associated antigen HER2/neu by human dendritic cells.The Biology and Underlying Mechanisms of Cross-Presentation of Exogenous Antigens on MHC-I Molecules.Exposure to Melan-A/MART-126-35 tumor epitope specific CD8(+)T cells reveals immune escape by affecting the ubiquitin-proteasome system (UPS)Exosome-driven transfer of tumor-associated Pioneer Translation Products (TA-PTPs) for the MHC class I cross-presentation pathway.Sec61 in antigen cross-presentation.Approaches to Improve Chemically Defined Synthetic Peptide Vaccines.Human in vivo-generated monocyte-derived dendritic cells and macrophages cross-present antigens through a vacuolar pathway.Vaccination of koalas (Phascolarctos cinereus) against Chlamydia pecorum using synthetic peptides derived from the major outer membrane protein.
P2860
Q26799991-58C2626F-696F-4B06-8CBC-1970C0504310Q36889732-27E3559B-87C2-4E3A-8858-034561E4F76EQ37260631-95CD0C0B-2978-4D04-9208-ADA84840C7B0Q37706835-762F38E0-78FE-4CD4-998C-D367FDD9B5D1Q38772920-5324BA61-ABD9-4999-A0D4-C8EAFD0CF3A1Q38801145-613720D2-654E-457F-9635-B2A5660F5DF8Q38869724-62CAD0F4-FA75-461B-805C-796B5580BA13Q39014554-427580E9-094B-4468-A40D-CEBEECF71F0CQ39104926-C382A4A3-6ED5-4B49-BD3C-99AA62C7C85FQ39796576-074C3131-C06E-45EC-980C-04B29246049EQ41298097-5DCADB96-6FA0-4E22-93E3-A4AECA8DB677Q43164223-49A14BA0-0586-4F80-97A2-9437D93A0BE7Q54961397-D635D3B9-78F4-4AAF-932A-17D64C600813Q55453765-2323F8A8-9A1B-4F99-A79B-0D0850A9DE7FQ55472927-27E74D6F-6F74-493F-88AD-C04512531D20
P2860
Cross-presentation of synthetic long peptides by human dendritic cells: a process dependent on ERAD component p97/VCP but Not sec61 and/or Derlin-1.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Cross-presentation of syntheti ...... but Not sec61 and/or Derlin-1.
@ast
Cross-presentation of syntheti ...... but Not sec61 and/or Derlin-1.
@en
type
label
Cross-presentation of syntheti ...... but Not sec61 and/or Derlin-1.
@ast
Cross-presentation of syntheti ...... but Not sec61 and/or Derlin-1.
@en
prefLabel
Cross-presentation of syntheti ...... but Not sec61 and/or Derlin-1.
@ast
Cross-presentation of syntheti ...... but Not sec61 and/or Derlin-1.
@en
P2093
P2860
P1433
P1476
Cross-presentation of syntheti ...... but Not sec61 and/or Derlin-1
@en
P2093
Andrea Lehmann
Francine Jotereau
Frédéric Ebstein
Peter-Michael Kloetzel
Philippe Hulin
Romain Oger
Steven Nedellec
Yannick Guilloux
P2860
P304
P356
10.1371/JOURNAL.PONE.0089897
P407
P577
2014-02-27T00:00:00Z